Hemofiltration of toxic mediator-related disease

Details Hemofiltration of toxic mediator-related disease Hemofiltration of toxic mediator-related disease

1994-07-06

1996-11-05

Kim, John

Liquid purification or separation

Processes

Liquid/liquid solvent or colloidal extraction or diffusing...

21050041, 210645, 210650, 604 4, 604 5, 604 6, B01D 6100, B01D 6114, A61M 138

Patent

active

055714188

ABSTRACT:
The present invention provides methods of treating pathophysiological states characterized by the presence in blood of certain toxic mediators. The novel method of hemofiltration of the present invention provides an effective treatment of several such disease including sepsis, shock, acute renal failure, multiple organ system failure and systemic inflammatory response syndrome-related diseases.

REFERENCES:
patent: 4229291 (1980-10-01), Walch et al.
patent: 4402940 (1983-09-01), Nose et al.
patent: 4874522 (1989-10-01), Okamoto et al.
patent: 4966709 (1990-10-01), Nos e et al.
Patricia A. Lee et al., Critical Care Medicine, vol. 21, No. 6, pp. 914-924 (Jun. 1993).
W. F. Koller et al., "CAVH in Acute Respiratory Failure," Int. Conf. on CAVH, Aachen 1984, pp. 96-102 (Karger, Basel 1985).
G. Zobel et al., Intensive Care Med, 17:315-319 (1991).
F. Coraim et al., "CAVH after Cardiac Surgery", Int. Conf. on CAVH, Aachen 1984, pp. 116-124 (Karger, Basel 1985).
Paul Sporn et al., First Vienna Shock Forum, Part B, pp. 225-233 (1987).

Affiliated with

Also associated with

Rating

Hemofiltration of toxic mediator-related disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hemofiltration of toxic mediator-related disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemofiltration of toxic mediator-related disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2012580